Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03790774 · ClinicalTrials.gov registry record · NA
Neurofeedback in Alzheimer's Disease
A NA study, sponsored by Oregon Health and Science University.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT03790774 is a NA study that was terminated before completion, run by Oregon Health and Science University. The registered enrollment target is 5 participants.
The verdict
NCT03790774, a NA study, was terminated before completion, sponsored by Oregon Health and Science University.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This study will evaluate behavioral and electrophysiological changes in a sample of adults with possible or probable Alzheimer's disease (AD), before and after undergoing training using a brain-computer interface (BCI) system with neurofeedback based on electroencephalography (EEG). Participants will repeatedly complete a letter viewing task and receive visual and auditory cues about their brainwaves. The study team hypothesizes that exposure to this EEG-based biofeedback intervention (neurofeedback) will result in a reduction of theta activity (brainwaves in the range of 4-8 Hz). The study team also predicts that exposure to the neurofeedback intervention will result in increased performance on reading, attention, and working memory tasks.
Interventions
- BEHAVIORAL Neurofeedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2019-06-06 |
| Est. Completion | 2020-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03790774
The ClinicalTrials.gov registry entry for NCT03790774 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Neurofeedback is the first listed.
NCT03790774 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03790774 about?
NCT03790774 is a clinical study titled "Neurofeedback in Alzheimer's Disease". This study will evaluate behavioral and electrophysiological changes in a sample of adults with possible or probable Alzheimer's disease (AD), before and after undergoing training using a brain-computer interface (BCI) system with neurofeedback based on electroencephalography (EEG). Participants wil...
What is the current status of trial NCT03790774?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2019-06-06. Estimated completion is 2020-08-01.
What interventions are being tested in trial NCT03790774?
The interventions under investigation include: Neurofeedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT03790774?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.